Cytosorbents (CTSO) Net Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly Net Margin came in at 57.86% in Q1 2026, down 4092.0% YoY from 1.45% in Q1 2025, and up 2.8% on a QoQ basis from 59.53% in Q4 2025.
Cytosorbents (CTSO) Net Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Net Margin data on file, last reported at 57.86% in Q1 2026.
- Quarterly Net Margin fell 4092.0% year-over-year to 57.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 31.85% (up 1374.0% YoY) and the FY2025 annual result came in at 22.12%, up 3609.0% from the prior year.
- Net Margin grew to 57.86% in Q1 2026, from 59.53% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 20.25% in Q2 2025 to a low of 150.42% in Q3 2022.
- A 5-year average of 63.88% and a median of 65.31% in 2023 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 7816 bps in 2022, down 8916 bps in 2022.
- Tracing CTSO's Net Margin over 5 years: stood at 8.16% in 2022, then plunged by 725 bps to 67.31% in 2023, then decreased by 23 bps to 82.69% in 2024, then gained by 28 bps to 59.53% in 2025, then gained by 3 bps to 57.86% in 2026.
- The last three Net Margin figures came in at 57.86% (Q1 2026), 59.53% (Q4 2025), and 33.42% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.47% |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -45.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45.85% |
| Mar 31, 2026 | -57.86% |
| Dec 31, 2025 | -59.53% |
| Sep 30, 2025 | -33.42% |
| Jun 30, 2025 | 20.25% |
| Mar 31, 2025 | -16.95% |
| Dec 31, 2024 | -82.69% |
| Sep 30, 2024 | -32.14% |
| Jun 30, 2024 | -48.56% |
| Mar 31, 2024 | -70.73% |
| Dec 31, 2023 | -67.31% |
| Sep 30, 2023 | -104.34% |
| Jun 30, 2023 | -65.31% |
| Mar 31, 2023 | -77.53% |
| Dec 31, 2022 | -8.16% |
| Sep 30, 2022 | -150.42% |
| Jun 30, 2022 | -128.06% |
| Mar 31, 2022 | -103.16% |
| Dec 31, 2021 | -86.32% |
| Sep 30, 2021 | -65.64% |